Clinical trial
Study of Nitazoxanide in the Treatment of Amebiasis in Children
NCT00366730 · Romark Laboratories L.C., Industry · Completed
Key facts
| NCT number | NCT00366730 |
|---|---|
| Title | Study of Nitazoxanide in the Treatment of Amebiasis in Children |
| Official title | Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Entamoeba Histolytica in Children |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Amebiasis |
| Intervention type | Drug |
| Interventions | Nitazoxanide |
| Enrollment | 50 |
| Start date | Feb 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Aug 21, 2006 |
| Last update posted | Aug 21, 2006 |
| Countries | Egypt |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: